BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31103442)

  • 1. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
    J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
    Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
    Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of ACR Lung-RADS in a clinical CT lung screening program.
    McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
    J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial.
    White CS; Dharaiya E; Dalal S; Chen R; Haramati LB
    Radiology; 2019 Apr; 291(1):205-211. PubMed ID: 30667335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Sundaram V; Gould MK; Nair VS
    Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial.
    Robbins HA; Katki HA; Cheung LC; Landy R; Berg CD
    J Thorac Oncol; 2019 Sep; 14(9):1662-1665. PubMed ID: 31125735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.
    Kessler A; Peng R; Mardakhaev E; Haramati LB; White CS
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190021. PubMed ID: 33778703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-low-dose CT reconstructed with ASiR-V using SmartmA for pulmonary nodule detection and Lung-RADS classifications compared with low-dose CT.
    Ye K; Chen M; Li J; Zhu Q; Lu Y; Yuan H
    Clin Radiol; 2021 Feb; 76(2):156.e1-156.e8. PubMed ID: 33293025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
    Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
    Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol and Rationale for the International Lung Screening Trial.
    Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S;
    Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
    van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
    Hammer MM; Eckel AL; Palazzo LL; Kong CY
    Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
    Hammer MM; Hunsaker AR
    AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
    [No Abstract]   [Full Text] [Related]  

  • 18. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
    Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
    Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
    Hammer MM; Byrne SC
    AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.